Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
McKesson
Citi
Teva
Deloitte
Harvard Business School
Julphar
McKinsey
Cantor Fitzgerald
AstraZeneca

Generated: October 23, 2017

DrugPatentWatch Database Preview

Spectinomycin hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for spectinomycin hydrochloride and what is the scope of spectinomycin hydrochloride freedom to operate?

Spectinomycin hydrochloride
is the generic ingredient in one branded drug marketed by Pfizer and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There are four drug master file entries for spectinomycin hydrochloride.

Summary for Generic Name: spectinomycin hydrochloride

US Patents:0
Tradenames:1
Applicants:1
NDAs:1
Drug Master File Entries: see list4
Bulk Api Vendors: see list81
Clinical Trials: see list2,287
Patent Applications: see list7,657
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:spectinomycin hydrochloride at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer
TROBICIN
spectinomycin hydrochloride
INJECTABLE;INJECTION050347-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Pfizer
TROBICIN
spectinomycin hydrochloride
INJECTABLE;INJECTION050347-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Healthtrust
Accenture
Cipla
AstraZeneca
Daiichi Sankyo
Johnson and Johnson
Chubb
Harvard Business School
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot